Abstract
The most prevalent genetic cause of both amyotrophic lateral sclerosis and frontotemporal dementia is a (GGGGCC) n nucleotide repeat expansion (NRE) occurring in the first intron of the C9orf72 gene (C9). Brain glucose hypometabolism is consistently observed in C9-NRE carriers, even at pre-symptomatic stages, but its role in disease pathogenesis is unknown. Here, we show alterations in glucose metabolic pathways and ATP levels in the brains of asymptomatic C9-BAC mice. We find that, through activation of the GCN2 kinase, glucose hypometabolism drives the production of dipeptide repeat proteins (DPRs), impairs the survival of C9 patient-derived neurons, and triggers motor dysfunction in C9-BAC mice. We also show that one of the arginine-rich DPRs (PR) could directly contribute to glucose metabolism and metabolic stress by inhibiting glucose uptake in neurons. Our findings provide a potential mechanistic link between energy imbalances and C9-ALS/FTD pathogenesis and suggest a feedforward loop model with potential opportunities for therapeutic intervention.
All Related Versions
Funding Information
  • National Institute on Aging (RF1-AG057882)
  • National Institute of Neurological Disorders and Stroke (R21-NS090912)
  • National Institute of Neurological Disorders and Stroke (RO1-NS109150)
  • National Institute of Neurological Disorders and Stroke (F31-NS118838)
  • National Institute of Neurological Disorders and Stroke (RF1-NS114128)
  • U.S. Army Medical Research Acquisition Activity (W81XWH-21-1-0134)
  • Muscular Dystrophy Association (628389)
  • Family Strong for ALS
  • Farber Family Foundation
  • Aldrich Foundation

This publication has 51 references indexed in Scilit: